E. Windsor, NJ, United States of America

Paul D Pansegrau


Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1995-1997

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Mind of Paul D. Pansegrau

Introduction

Paul D. Pansegrau, based in E. Windsor, NJ, is a notable inventor with a commendable portfolio of five patents. His work primarily focuses on innovations in the field of medicinal chemistry, particularly involving prostaglandin analogs, an area vital for developing anti-thrombotic and anti-vasospastic treatments.

Latest Patents

One of Pansegrau's latest patents includes novel 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates. This invention relates to unique intermediates that can be utilized in the synthesis of effective anti-thrombotic and anti-vasospastic pharmaceutical products. Moreover, he has patented a method for preparing these unique carboxylic acid intermediates, further advancing the applications of his research.

Career Highlights

In his professional journey, Paul has made significant contributions while working at Bristol-Myers Squibb Company. His innovative spirit and expertise in drug development have been crucial in pushing the boundaries of what is possible in pharmaceutical science.

Collaborations

Throughout his career, Pansegrau has collaborated with esteemed coworkers such as Michael A. Poss and Shaopeng Wang. Their collective efforts have not only enriched their research projects but have also fostered an environment of innovation within their team.

Conclusion

Paul D. Pansegrau stands out as a remarkable inventor whose contributions to the field of medicinal chemistry continue to bear significant implications for healthcare. His innovative insights and collaborative spirit exemplify the essence of advancing science through dedicated research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…